Ferroptosis
Ferroptosis is a unique iron-dependent form of nonapoptotic cell death. It is triggered by oncogenic RAS-selective lethal small molecule erastin. Acitvation of ferroptosis lead to nonapoptotic destruction of cancer cells.
Products for Ferroptosis
- Cat.No. Product Name Information
- GC50345 Liproxstatin-1 hydrochloride Potent ferroptosis inhibitor
- GC11633 Lovastatin An inhibitor of HMG-CoA reductase
-
GC44214
ML-162
ML-162 is a GPX4 inhibitor that is selectively lethal to mutant RAS oncogene-expressing cell lines (IC50s = 25 and 578 nM for HRASG12V-expressing and wild-type BJ fibroblasts, respectively).
-
GC18705
ML-210
A GPX4 inhibitor
-
GC19254
ML385
ML385 is a specific nuclear factor erythroid 2-related factor 2 (NRF2) inhibitor.
- GC68479 MMRi62
-
GC33469
NADPH tetracyclohexanamine
A reduced form of NADP+
-
GC34058
NADPH tetrasodium salt
A reduced form of NADP+
-
GC11008
Necrostatin-1
A RIP1 kinase inhibitor
- GC18089 Nordihydroguaiaretic acid A non-selective LO inhibitor
- GC47870 Pantothenate Kinase Inhibitor A reversible inhibitor of pantothenate kinase
-
GC12205
PD 146176
PD 146176 is one of the potent and selective inhibitors of reticulocyte 15-LOX-1.
- GC10538 Pifithrin-α (PFTα) Pifithrin-α(PFT-α) is a p53 inhibitor. Pifithrin-αwidely used in neuroscience to block neuronal apoptotic cell death. Pifithrin-αis also a potent stimulant of aryl hydrocarbon receptor (AhR)..
- GC14948 Pioglitazone Pioglitazone (PIO) is a thiazolidinedione antidiabetic drug that acts as a PPARγ agonist. The EC50 of PPARγ in human and mouse was 0.93 and 0.99 µM, respectively..
- GC61187 Pioglitazone D4 An internal standard for the quantification of pioglitazone
- GC11152 Pioglitazone HCl A PPARγ agonist
- GC36926 Piperazine Erastin
- GC10282 Piperlongumine An alkaloid with anticancer and antioxidant activities
- GC14538 Pravastatin sodium A potent HMG-CoA reductase inhibitor
- GC12086 PRIMA-1 A re-activator of the apoptotic function of mutant p53 proteins
- GN10361 Pseudolaric Acid B
- GC49691 PSP A two-photon fluorescent probe for H2Sn
- GC48029 RC363 An inhibitor of ferroptosis
- GC48030 RC574 An inhibitor of ferroptosis
-
GC16444
Rosiglitazone
A PPARγ agonist
- GC44851 Rosiglitazone (potassium salt) Rosiglitazone (BRL 49653) potassium is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM).
- GC11318 Rosiglitazone maleate A PPARγ agonist
- GC48059 Rosiglitazone-d3 An internal standard for the quantification of rosiglitazone
-
GC12431
RSL3
Glutathione peroxidase 4 inhibitor
- GC13968 SB202190 (FHPI) SB202190 (FHPI) is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively.
- GC10585 Simvastatin (Zocor) Simvastatin (Zocor) (MK 733) is a competitive inhibitor of HMG-CoA reductase with a Ki of 0.2 nM.
- GC13083 Siramesine Siramesine (Lu 28-179) is a potent sigma-2 receptor agonist. Siramesine has a subnanomolar affinity for sigma-2 receptors (IC50=0.12nM) and exhibits a 140-fold selectivity for sigma-2 receptors over sigma-1 receptors (IC50=17nM). Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes. Anti-cancer activity.
- GC44893 Siramesine (fumarate) Siramesine is an agonist of the sigma-2 (σ2) receptor (IC50 = 0.19 nM).
-
GC15222
Siramesine hydrochloride
Sigma-2 receptor agonist
-
GC17369
Sorafenib
Sorafenib acts as a multi-kinase inhibitor, targeting Raf-1 and B-Raf with IC50 values of 6 nM and 22 nM, respectively.
- GC37664 Sorafenib (D3) An internal standard for the quantification of sorafenib
- GC37665 Sorafenib (D4) Sorafenib (D4) (Bay 43-9006-d4) is the deuterium labeled Sorafenib. Sorafenib is a multikinase inhibitor IC50s of 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively.
- GC40922 SRS11-92 SRS11-92 is a ferroptosis inhibitor and a derivative of ferrostatin-1.
- GC44947 SRS16-86 A ferroptosis inhibitor
- GC16868 Sulfasalazine NF-κB activation inhibitor
- GC34057 TBHQ (tert-Butylhydroquinone) TBHQ (tert-Butylhydroquinone) (tert-Butylhydroquinone) is a widely used Nrf2 activator, protects against Doxorubicin (DOX)-induced cardiotoxicity through activation of Nrf2. TBHQ (tert-Butylhydroquinone) (tert-Butylhydroquinone) is also an ERK activator; rescues Dehydrocorydaline (DHC)-induced cell proliferation inhibitionin melanoma.
- GN10289 Trigonelline
- GC15272 Troglitazone Selective PPARγ agonist
- GC19457 Trolox Trolox is a cell-permeable, water-soluble derivative of vitamin E with potent antioxidant properties.
- GC10451 U-73122 Inhibitor of phospholipase C, phospholipase A2, and 5-LO
- GC40193 UAMC-3203 UAMC-3203 is an inhibitor of ferroptosis that has an IC50 value of 10 nM for inhibition of erastin-induced ferroptosis in IMR-32 neuroblastoma cells.
- GC34939 UAMC-3203 hydrochloride A ferroptosis inhibitor
- GC49308 Ungeremine A betaine-type alkaloid with diverse biological activities
- GC30512 Vatiquinone (EPI-743) Vatiquinone (EPI-743) (Vatiquinone; α-Tocotrienol quinone; PTC-743; NCT04378075) is a potent cellular oxidative stress protectant, inhibits ferroptosis in cells, which could be used for the study for mitochondrial diseases.
- GC16733 Vildagliptin (LAF-237) A DPP-4 inhibitor
- GC31492 Vildagliptin dihydrate (LAF237 dihydrate) Vildagliptin dihydrate (LAF237 dihydrate) (LAF237 dihydrate) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells.
-
GC10042
Vitamin E
fat-soluble vitamin
- GC17309 Withaferin A Prevents NF-κB activation by inhibiting activation of IKKβ
-
GC70157
YL-939
YL-939 is an effective inhibitor of ferroptosis. YL-939 inhibits ferroptosis by targeting PHB2/ferritin/iron axis.
-
GC16014
Zileuton
5-lipoxygenase (5-LOX) inhibitor, orally active